VISUAL EYE CREATIONS LIMITED

Company number 14238209 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

VISUAL EYE CREATIONS LIMITED - Analysis Report

Company Number: 14238209

Analysis Date: 2025-07-29 14:35 UTC

Financial Health Assessment of Visual Eye Creations Limited (as at 31 July 2024)


1. Financial Health Score: D

Explanation:
Visual Eye Creations Limited shows minimal net assets (£11) and very low working capital, with cash of only £2,211 against current liabilities of £2,200. The profit and loss reserve is negative (-£89), indicating accumulated losses or expenses exceeding income. The company is very young (incorporated July 2022) and currently has no employees, which may explain minimal operational scale. These figures suggest the company is in a fragile financial state, with symptoms of financial distress such as minimal buffer against liabilities and no retained earnings. Overall, the company’s financial health is weak and requires careful monitoring and remedial action.


2. Key Vital Signs (Critical Metrics & Interpretation)

Metric 2024 Figure Interpretation
Cash at Bank £2,211 Very low cash reserves; healthy cash flow requires a higher buffer to meet short-term obligations.
Current Liabilities £2,200 Almost equal to cash, indicating tight liquidity and limited breathing room.
Net Current Assets £11 Near zero working capital, signaling risk in meeting short-term debts without additional funding.
Net Assets (Shareholders' Funds) £11 Extremely low equity base, reflecting minimal capital and potential erosion of value.
Profit & Loss Account -£89 Negative retained earnings; company may be incurring losses or has not yet generated profits.
Employees 0 No employees reported, potentially indicating limited operational activity or outsourcing.
Company Age 2 years Early stage; may still be in setup or investment phase, but fragile financial footing persists.

3. Diagnosis (What the Financial Data Reveals)

Visual Eye Creations Limited is in the early life cycle stage of development, with limited financial resources and very thin liquidity. The company’s cash position narrowly covers its current liabilities, leaving little room for operational flexibility or unexpected expenses. The negative profit and loss reserve signals that the company may be spending more than it earns, representing a symptom of financial strain, although this could also reflect initial startup costs.

The absence of employees indicates that the company may be operating on a very small scale or outsourcing work, which can reduce fixed overhead but also limits growth potential. Overall, the financial "vital signs" suggest the company is under stress and vulnerable to cash flow shocks. Without strengthening cash reserves or improving profitability, the risk of financial distress or inability to meet obligations in the short term is elevated.


4. Recommendations (Specific Actions to Improve Financial Wellness)

  • Strengthen Cash Reserves: Seek additional funding from shareholders, investors, or short-term credit facilities to build a healthy cash buffer. This is critical to avoid liquidity crises.

  • Monitor and Control Expenses: Review and reduce operating expenses to prevent further erosion of retained earnings and preserve cash.

  • Revenue Growth Initiatives: Focus on securing contracts or sales to increase turnover and generate positive margins, turning the cash flow from negative to positive.

  • Regular Financial Monitoring: Implement monthly cash flow forecasts and financial reviews to detect symptoms of distress early and respond promptly.

  • Consider Strategic Partnerships: Explore alliances or outsourcing that can increase operational capacity without significant fixed costs.

  • Review Capital Structure: If possible, inject additional equity capital to strengthen the balance sheet and improve net assets.


Medical Analogy Summary

Visual Eye Creations Limited shows “symptoms of financial distress” with a dangerously low liquidity “pulse” and a weak “immune system” (equity base). The company is akin to a patient in the early stages of illness who requires immediate supportive care—boosting cash flow and controlling costs—to prevent deterioration into “financial shock.” Timely intervention will be key to restoring “financial health” and enabling sustainable growth.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.